COMPASS Pathways Plc (CMPS)

$3.77

up-down-arrow $-0.11 (-2.84%)

As on 29-Apr-2025 16:00EDT

COMPASS Pathways Plc (CMPS) Share Price

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 3.74 High: 4.00

52 Week Range

Low: 2.49 High: 9.63

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    $370 Mln

  • P/E RatioP/E Ratio information

    --

  • P/B RatioP/B Ratio information

    2.29

  • Industry P/EIndustry P/E information

    --

  • Debt to EquityDebt to Equity information

    0.05

  • ROEROE information

    -0.82 %

  • ROCEROCE information

    -73.69 %

  • Div. YieldDiv. Yield information

    0 %

  • Book ValueBook Value information

    2.31

  • EPSEPS information

    -2.32

6 Years Aggregate

CFO

$-339.94 Mln

EBITDA

$-373.92 Mln

Net Profit

$-375.34 Mln

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
COMPASS Pathways (CMPS)
-0.26 28.23 -4.31 -52.52 -26.57 -- --
BSE Sensex*
2.55 3.65 4.54 7.46 12.04 19.65 11.41
As on 29-Apr-2025  |  *As on 30-Apr-2025
2024
2023
2022
2021
COMPASS Pathways (CMPS)
-56.50 8.97 -63.67 -53.61
BSE Sensex
8.10 18.74 4.44 21.99
BSE Sensex
8.10 18.74 4.44 21.99

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

Detailed View
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View All
loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer

View All
Company
Price ($) Market Cap ($ Mln) P/E Ratio ROE
38.55 10,593.45 21.84 23.13
306.35 8,570.17 22.78 66.44
27.82 10,589.59 -- -28.77
107.24 10,559.67 32.44 14.16

Shareholding Pattern

Detailed Holdings
loading...
BLAHBLAH

About The Company

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of...  treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ  Read more

  • CEO & Director

    Mr. Kabir Nath M.A., M.B.A.

  • CEO & Director

    Mr. Kabir Kumar Nath M.A., M.B.A.

  • Headquarters

    London

  • Website

    https://compasspathways.com

Edit peer-selector-edit
loading...
loading...

FAQs for COMPASS Pathways Plc (CMPS)

The total asset value of COMPASS Pathways Plc (CMPS) stood at $ 214 Mln as on 31-Dec-24

The share price of COMPASS Pathways Plc (CMPS) is $3.77 (NASDAQ) as of 29-Apr-2025 16:00 EDT. COMPASS Pathways Plc (CMPS) has given a return of -26.57% in the last 3 years.

COMPASS Pathways Plc (CMPS) has a market capitalisation of $ 370 Mln as on 29-Apr-2025. As per Value Research classification, it is a company.

Since, TTM earnings of COMPASS Pathways Plc (CMPS) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the COMPASS Pathways Plc (CMPS) and enter the required number of quantities and click on buy to purchase the shares of COMPASS Pathways Plc (CMPS).

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ

The CEO & director of Mr. Kabir Nath M.A., M.B.A.. is COMPASS Pathways Plc (CMPS), and CFO & Sr. VP is Mr. Kabir Kumar Nath M.A., M.B.A..

There is no promoter pledging in COMPASS Pathways Plc (CMPS).

COMPASS Pathways Plc (CMPS) Ratios
Return on equity(%)
-81.55
Operating margin(%)
--
Net Margin(%)
--
Dividend yield(%)
--

No, TTM profit after tax of COMPASS Pathways Plc (CMPS) was $0 Mln.